Neuroone Medical Technologies Corp (NMTC) Stock Price, Quote & News

Company Profile

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-...

Industry: Medical Devices

Sector: Healthcare

Phone: 952 426 1383

Website: nmtc1.com

Address:

7599 Anagram Drive, Eden Prairie, United States

dario2580 Aug. 8 at 1:03 AM

$NMTC FDA/clinical catalysts can move the stock sharply🚀

0 · Reply

MarianneV Aug. 7 at 1:40 AM

$NMTC

0 · Reply

StockShockFever Aug. 6 at 6:52 PM

$NMTC There seems to be a pattern. Believers post articles that are almost meaningless to NMTC and the stock price goes down. This may dive down after earnings?

1 · Reply

Wisenheimer Aug. 6 at 6:07 PM

$NMTC I think whats going on is a potential “going concern” issue w virtually no cash left given burn and need to show probably at least 8mm in cash before the 09/30 yr end filing - should have opted for the 12/1 vs 6/1 reverse

0 · Reply

IncognitoBull Aug. 5 at 2:58 PM

$NMTC Staudt uses the tech for epilepsy and TN

0 · Reply

Wisenheimer Aug. 4 at 7:38 PM

$NMTC can anyone say

0 · Reply

IncognitoBull Aug. 3 at 4:01 PM

$NMTC

0 · Reply

MarianneV Aug. 1 at 11:33 PM

$NMTC I don’t want to seem like I’m trying to come across as an expert. I’m a newby investor trying to follow what is going on with the company and their products myself. Waiting on the stockholders ER, I think about August 14th, to see what kind of news they will put out there then.

1 · Reply

StockShockFever Aug. 1 at 11:23 PM

$NMTC How many years away do you think this future revenue pipeline is before the future revenue starts? Now much money do you think they will have to raise to get to that future point in time? If NMTC was at $9.50 at the beginning of 2024, do you think a big pharma buy out can happen at 10 times it's current price so that there will be at least a slight profit over the last 2 years?

1 · Reply

MarianneV Aug. 1 at 11:09 PM

$NMTC

0 · Reply

NeuroOne Medical Technologies Transcript: Planet MicroCap Las Vegas 2026

Jun 12, 2026, 7:00 AM EDT - 2 months ago

NeuroOne Medical Technologies Slides: Corporate presentation

2026-05-13T12:05:31.000Z - 3 months ago

NeuroOne Medical target adjusted to $8 from $1.60 at Ladenburg

May 12, 2026, 8:30 AM EDT - 3 months ago

NeuroOne Medical Technologies Earnings Call Transcript: Q2 2026

May 12, 2026, 8:30 AM EDT - 3 months ago

NeuroOne Medical Technologies Earnings release: Q2 2026

May 12, 2026, 8:30 AM EDT - 3 months ago

NeuroOne Medical Technologies Quarterly report: Q2 2026

2026-04-15T23:50:16.000Z - 4 months ago

NeuroOne Medical Technologies trading halted, news pending

Mar 17, 2026, 1:20 PM EDT - 5 months ago

NeuroOne Medical Technologies Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 12, 2026, 11:30 AM EDT - 5 months ago

NeuroOne Medical Technologies Transcript: Investor update

Mar 11, 2026, 8:00 AM EDT - 5 months ago

NeuroOne Medical Technologies Slides: Corporate presentation

Mar 9, 2026, 8:00 AM EDT - 5 months ago

NeuroOne Medical Technologies Proxy statement: Proxy Filing

2026-03-02T12:24:18.000Z - 5 months ago

NeuroOne Medical initiated with a Buy at JonesResearch

Feb 27, 2026, 7:00 AM EST - 5 months ago

NeuroOne Medical Technologies Proxy statement: Proxy Filing

Feb 17, 2026, 8:30 AM EST - 6 months ago

NeuroOne Medical Technologies Earnings Call Transcript: Q1 2026

Feb 17, 2026, 8:30 AM EST - 6 months ago

NeuroOne Medical Technologies Earnings release: Q1 2026

Feb 17, 2026, 8:30 AM EST - 6 months ago

NeuroOne Medical Technologies Quarterly report: Q1 2026

Dec 22, 2025, 6:00 AM EST - 8 months ago

NeuroOne Medical Technologies Slides: Corporate presentation

Dec 17, 2025, 8:30 AM EST - 8 months ago

NeuroOne Medical Technologies Earnings Call Transcript: Q4 2025

Dec 17, 2025, 8:30 AM EST - 8 months ago

NeuroOne Medical Technologies Earnings release: Q4 2025

Dec 17, 2025, 8:30 AM EST - 8 months ago

NeuroOne Medical Technologies Annual report: Q4 2025

Oct 7, 2025, 8:30 AM EDT - 10 months ago

NeuroOne Medical Technologies Transcript: Investor Update

Sep 17, 2025, 12:15 PM EDT - 11 months ago

NeuroOne Medical Technologies Transcript: Small-Cap Virtual Conference

2025-09-09T11:50:39.000Z - 11 months ago

NeuroOne Medical initiated with a Buy at Maxim

Sep 8, 2025, 4:05 PM EDT - 11 months ago

NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025

2025-08-18T12:35:36.000Z - 1 year ago

NeuroOne Medical receives FDA 510k clearance for OneRF

Aug 18, 2025, 8:30 AM EDT - 1 year ago

NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Aug 14, 2025, 8:30 AM EDT - 1 year ago

NeuroOne Medical Technologies Earnings Call Transcript: Q3 2025

Aug 14, 2025, 8:30 AM EDT - 1 year ago

NeuroOne Medical Technologies Quarterly report: Q3 2025

Aug 14, 2025, 8:30 AM EDT - 1 year ago

NeuroOne Medical Technologies Earnings release: Q3 2025

Aug 14, 2025, 7:30 AM EDT - 1 year ago

NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%

Jul 31, 2025, 12:12 PM EDT - 1 year ago

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

Jul 31, 2025, 8:30 AM EDT - 1 year ago

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

2025-07-23T12:46:23.000Z - 1 year ago

NeuroOne Medical receives notice of allowance for key patent from USPTO

Jul 23, 2025, 8:30 AM EDT - 1 year ago

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

2025-06-23T17:55:45.000Z - 1 year ago

NeuroOne Medical reports patient surpasses one year milestone of seizure freedom

Jun 23, 2025, 8:30 AM EDT - 1 year ago

NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System

2025-06-03T12:40:40.000Z - 1 year ago

NeuroOne Medical appoints Johns as General Counsel, Corporate Secretary

Jun 3, 2025, 8:30 AM EDT - 1 year ago

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

May 29, 2025, 1:05 PM EDT - 1 year ago

NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

NeuroOne Medical Technologies Earnings Call Transcript: Q2 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

NeuroOne Medical Technologies Quarterly report: Q2 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

NeuroOne Medical Technologies Earnings release: Q2 2025

May 13, 2025, 7:30 AM EDT - 1 year ago

NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%

2025-05-12T12:42:19.000Z - 1 year ago

NeuroOne Medical appoints Parag Patil as chief medical advisor

May 12, 2025, 8:30 AM EDT - 1 year ago

NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor

May 12, 2025, 7:00 AM EDT - 1 year ago

NeuroOne Medical Technologies Slides: Corporate Presentation

May 5, 2025, 4:01 PM EDT - 1 year ago

NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference

2025-05-05T11:16:33.000Z - 1 year ago

NeuroOne Medical initiated with a Buy at Ladenburg

May 1, 2025, 9:55 AM EDT - 1 year ago

NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time

Apr 23, 2025, 9:00 AM EDT - 1 year ago

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Apr 16, 2025, 9:00 AM EDT - 1 year ago

NeuroOne® Issues Letter to Shareholders

Apr 14, 2025, 9:00 AM EDT - 1 year ago

NeuroOne® OneRF® Technology Success Story Featured on Fox News

Apr 4, 2025, 8:30 AM EDT - 1 year ago

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

Apr 3, 2025, 4:05 PM EDT - 1 year ago

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

Mar 18, 2025, 1:12 PM EDT - 1 year ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - Update

Mar 18, 2025, 9:00 AM EDT - 1 year ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace

Mar 18, 2025, 8:46 AM EDT - 1 year ago

NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy

Mar 11, 2025, 9:00 AM EDT - 1 year ago

NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Mar 5, 2025, 9:00 AM EST - 1 year ago

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Feb 12, 2025, 8:30 AM EST - 1 year ago

NeuroOne Medical Technologies Earnings Call Transcript: Q1 2025

Feb 12, 2025, 8:30 AM EST - 1 year ago

NeuroOne Medical Technologies Quarterly report: Q1 2025

Feb 12, 2025, 8:30 AM EST - 1 year ago

NeuroOne Medical Technologies Earnings release: Q1 2025

Feb 12, 2025, 8:00 AM EST - 1 year ago

NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update

Feb 7, 2025, 7:00 AM EST - 1 year ago

NeuroOne Medical Technologies Proxy statement: Proxy Filing

Feb 5, 2025, 11:00 AM EST - 1 year ago

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time

Feb 5, 2025, 7:00 AM EST - 1 year ago

NeuroOne Medical Technologies Proxy statement: Proxy Filing

Feb 4, 2025, 10:56 AM EST - 1 year ago

NeuroOne® Regains Compliance with Nasdaq Listing Requirements

Jan 21, 2025, 7:00 AM EST - 1 year ago

NeuroOne Medical Technologies Proxy statement: Proxy Filing

Jan 13, 2025, 7:00 AM EST - 1 year ago

NeuroOne Medical Technologies Proxy statement: Proxy Filing

Jan 10, 2025, 11:00 AM EST - 1 year ago

NeuroOne Medical Technologies Transcript: Status Update

Jan 10, 2025, 11:00 AM EST - 1 year ago

NeuroOne Medical Technologies Slides: Status Update

Jan 10, 2025, 8:30 AM EST - 1 year ago

NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million

Jan 10, 2025, 7:00 AM EST - 1 year ago

NeuroOne Medical Technologies Proxy statement: Proxy Filing

Jan 3, 2025, 8:30 AM EST - 1 year ago

NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST

Dec 17, 2024, 9:00 AM EST - 1 year ago

NeuroOne Medical Technologies Earnings Call Transcript: Q4 2024

Dec 17, 2024, 9:00 AM EST - 1 year ago

NeuroOne Medical Technologies Annual report: Q4 2024

Dec 17, 2024, 8:30 AM EST - 1 year ago

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

Nov 13, 2024, 9:30 AM EST - 1 year ago

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

Oct 31, 2024, 4:01 PM EDT - 1 year ago

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

Sep 24, 2024, 9:30 AM EDT - 2 years ago

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

Sep 12, 2024, 8:00 AM EDT - 2 years ago

NeuroOne Medical Technologies Registration statement: Registration Filing

Sep 10, 2024, 9:00 AM EDT - 2 years ago

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

Sep 5, 2024, 6:23 PM EDT - 2 years ago

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 30, 2024, 8:00 AM EDT - 2 years ago

NeuroOne Medical Technologies Registration statement: Registration Filing

Aug 14, 2024, 4:30 PM EDT - 2 years ago

NeuroOne Medical Technologies Earnings Call Transcript: Q3 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

NeuroOne Medical Technologies Quarterly report: Q3 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

NeuroOne Medical Technologies Earnings release: Q3 2024

Aug 14, 2024, 4:00 PM EDT - 2 years ago

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Aug 14, 2024, 8:00 AM EDT - 2 years ago

NeuroOne Medical Technologies Registration statement: Registration Filing

Aug 12, 2024, 11:30 AM EDT - 2 years ago

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

Jun 20, 2024, 9:30 AM EDT - 2 years ago

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

May 31, 2024, 8:00 AM EDT - 2 years ago

NeuroOne Medical Technologies Registration statement: Registration Filing

May 14, 2024, 4:30 PM EDT - 2 years ago

NeuroOne Medical Technologies Earnings Call Transcript: Q2 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

NeuroOne Medical Technologies Quarterly report: Q2 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

NeuroOne Medical Technologies Earnings release: Q2 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

May 10, 2024, 2:43 PM EDT - 2 years ago

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14

Apr 10, 2024, 9:00 AM EDT - 2 years ago

NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology

Apr 9, 2024, 9:05 AM EDT - 2 years ago

NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes

Apr 4, 2024, 9:00 AM EDT - 2 years ago

NeuroOne® CEO Dave Rosa Featured on Fox Business Network's Varney & Co.

Mar 26, 2024, 9:00 AM EDT - 2 years ago

NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System

Mar 8, 2024, 12:00 PM EST - 2 years ago

NeuroOne® to Participate in the 36th Annual Roth Conference

Feb 23, 2024, 5:10 PM EST - 2 years ago

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Feb 13, 2024, 4:30 PM EST - 2 years ago

NeuroOne Medical Technologies Earnings Call Transcript: Q1 2024

Feb 13, 2024, 4:30 PM EST - 2 years ago

NeuroOne Medical Technologies Quarterly report: Q1 2024

Feb 13, 2024, 4:30 PM EST - 2 years ago

NeuroOne Medical Technologies Earnings release: Q1 2024

Feb 13, 2024, 4:00 PM EST - 2 years ago

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Feb 8, 2024, 3:30 PM EST - 2 years ago

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13

Jan 29, 2024, 7:00 AM EST - 2 years ago

NeuroOne Medical Technologies Proxy statement: Proxy Filing

Dec 14, 2023, 5:00 PM EST - 2 years ago

NeuroOne Medical Technologies Earnings Call Transcript: Q4 2023

Dec 14, 2023, 5:00 PM EST - 2 years ago

NeuroOne Medical Technologies Annual report: Q4 2023

Dec 14, 2023, 5:00 PM EST - 2 years ago

NeuroOne Medical Technologies Earnings release: Q4 2023

Dec 14, 2023, 4:15 PM EST - 2 years ago

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update

Dec 7, 2023, 4:30 PM EST - 2 years ago

NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14

Nov 16, 2023, 8:00 AM EST - 2 years ago

NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe

dario2580 Aug. 8 at 1:03 AM

$NMTC FDA/clinical catalysts can move the stock sharply🚀

0 · Reply

MarianneV Aug. 7 at 1:40 AM

$NMTC

0 · Reply

StockShockFever Aug. 6 at 6:52 PM

$NMTC There seems to be a pattern. Believers post articles that are almost meaningless to NMTC and the stock price goes down. This may dive down after earnings?

1 · Reply

Wisenheimer Aug. 6 at 6:07 PM

0 · Reply

IncognitoBull Aug. 5 at 2:58 PM

$NMTC Staudt uses the tech for epilepsy and TN

0 · Reply

Wisenheimer Aug. 4 at 7:38 PM

$NMTC can anyone say

0 · Reply

IncognitoBull Aug. 3 at 4:01 PM

$NMTC

0 · Reply

MarianneV Aug. 1 at 11:33 PM

1 · Reply

StockShockFever Aug. 1 at 11:23 PM

1 · Reply

MarianneV Aug. 1 at 11:09 PM

$NMTC

0 · Reply

MarianneV Aug. 1 at 11:07 PM

$NMTC

0 · Reply

IncognitoBull Jul. 31 at 1:32 PM

$NMTC https://www.barchart.com/story/news/3561154/neuroone-releases-cns-drug-delivery-white-paper-ahead-of-planned-fiscal-year-end-availability-of-the-stereocedtm-platform

0 · Reply

MarianneV Jul. 30 at 12:33 AM

$NMTC

0 · Reply

StockShockFever Jul. 29 at 9:04 PM

$NMTC Except that they have nothing to do with each other. One is a biologic injected or transplanted into tissue. The other is a hardware device. Please explain how stem cells are a possible market for NeuroOne. Is CAR-T therapy also a possible market for NeuroOne? Is CRISPR therapy also a possible market for NeuroOne? Or MRNA, or RNAI, or Kinase inhibitors? That's like saying a new gold ball will improve sales of a basketball manufacturer.

1 · Reply

MarianneV Jul. 29 at 3:47 PM

$NMTC Once again, a possible market.

0 · Reply

JohnStuartMill Jul. 28 at 4:43 PM

$NMTC Apparently LOWER.

0 · Reply

MarianneV Jul. 28 at 4:03 PM

$NMTC I’m regularly trolling for bits of info @ NMTC. Thought I might start posting here and there if anyone is interested. I liked learning this:

1 · Reply

MarianneV Jul. 28 at 3:59 PM

$NMTC What a loss on so many levels.

0 · Reply

Wisenheimer Jul. 28 at 1:51 PM

$NMTC its also sad that their 1 of their 2 main procedure Dr’s recently passed away.

0 · Reply

MarianneV Jul. 28 at 12:50 AM

$NMTC Expecting them to deliver!

0 · Reply

Wisenheimer Jul. 27 at 9:03 PM

$NMTC management team paid wayyy too much

0 · Reply

JohnStuartMill Jul. 27 at 7:23 PM

$NMTC ?????????????????

0 · Reply

Market Cap	14.19M
Revenue (ttm)	12.10M
Net Income (ttm)	-3.61M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-29.83%
Debt to Equity Ratio	0.00

Volume	157,800
Avg Vol	44,988
Day's Range	N/A - N/A
Shares Out	8.70M
Stochastic %K	37%
Beta	0.61
Analysts	Strong Sell
Price Target	$9.93